Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Free Cash Flow (2022 - 2025)

Neuraxis' Free Cash Flow history spans 4 years, with the latest figure at -$1.4 million for Q3 2025.

  • For Q3 2025, Free Cash Flow fell 2.17% year-over-year to -$1.4 million; the TTM value through Sep 2025 reached -$6.3 million, up 10.43%, while the annual FY2024 figure was -$6.1 million, 8.9% up from the prior year.
  • Free Cash Flow for Q3 2025 was -$1.4 million at Neuraxis, up from -$1.5 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$204315.0 in Q4 2022 and bottomed at -$2.8 million in Q3 2023.
  • The 4-year median for Free Cash Flow is -$1.4 million (2025), against an average of -$1.4 million.
  • The largest annual shift saw Free Cash Flow tumbled 1194.86% in 2023 before it skyrocketed 50.44% in 2024.
  • A 4-year view of Free Cash Flow shows it stood at -$204315.0 in 2022, then crashed by 1194.86% to -$2.6 million in 2023, then skyrocketed by 33.54% to -$1.8 million in 2024, then grew by 18.81% to -$1.4 million in 2025.
  • Per Business Quant, the three most recent readings for NRXS's Free Cash Flow are -$1.4 million (Q3 2025), -$1.5 million (Q2 2025), and -$1.6 million (Q1 2025).